Freed-amino acids in human cerebrospinal fluid of alzheimer disease, multiple sclerosis, and healthy control subjects
Molecular and Chemical Neuropathology1994Vol. 23(2-3), pp. 115–124
Citations Over Time
G. H. Fisher, Leonard Petrucelli, Christina L. Gardner, Carolyn Emory, William H. Frey, Luigi Amaducci, Sandro Sorbi, Giovanna Sorrentino, Mauro Borghi, Antimo D'aniello
Related Papers
- → “Compensated hyperosmolarity” of cerebrospinal fluid and the development of hydrocephalus(2013)52 cited
- → Lipoprotein(a) in the Cerebrospinal Fluid of Neurological Patients with Blood–Cerebrospinal Fluid Barrier Dysfunction(2006)13 cited
- → Cerebrospinal Fluid Thyroxine(1969)9 cited
- → Relation of fingolimod treatment to disability in multiple sclerosis(2017)
- → Role of Plasma MicroRNAs 145 and 484 in Diagnosis of Multiple Sclerosis, Disease Activity and the Transition from Relapsing Remitting Multiple Sclerosis to Secondary Progressive Multiple Sclerosis(2023)